By Michael Cintolo, Cabot Heritage Corporation
GenMark (GNMK) is a testing company. Its proprietary eSensor detection technology (dubbed eSensor XT-8) and ePlex systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations, and self-contained, disposable test cartridges.
And its ePlex offering optimizes laboratory efficiencies and addresses a broad range of infectious disease testing needs. Its ePlex SARS-CoV-2 Test, an in-vitro diagnostic (IVD), has been made available under an emergency access mechanism by the Secretary of Health and Human Service for COVID-19 testing.
While not yet approved